Peter J Barnes Selected Research

8-epi-prostaglandin F2alpha

5/2022	Oxidative Stress in Chronic Obstructive Pulmonary Disease.
1/2011	Correlation between eicosanoids in bronchoalveolar lavage fluid and in exhaled breath condensate.
1/2010	Measurement of 8-isoprostane in exhaled breath condensate.
2/2009	Effects of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on nitric oxide production and its metabolites in healthy control subjects, healthy smokers, and COPD patients.
9/2008	Exhaled 8-isoprostane and prostaglandin E(2) in patients with stable and unstable cystic fibrosis.
8/2006	Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.
7/2005	Exhaled 8-isoprostane in childhood asthma.
10/2004	Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children.
1/2004	Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease.
10/2003	8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter J Barnes Research Topics

Disease

219	Chronic Obstructive Pulmonary Disease (COPD) 05/2022 - 01/2002
183	Asthma (Bronchial Asthma) 01/2022 - 01/2002
128	Inflammation (Inflammations) 05/2022 - 01/2002
19	Lung Diseases (Lung Disease) 01/2021 - 01/2002
14	Pneumonia (Pneumonitis) 01/2021 - 04/2002
10	Disease Progression 01/2022 - 01/2003
10	Cough 01/2018 - 06/2002
9	Cystic Fibrosis (Mucoviscidosis) 12/2013 - 01/2002
8	Necrosis 01/2022 - 01/2003
8	Infections 01/2022 - 04/2009
8	Emphysema 01/2020 - 05/2002
8	Fibrosis (Cirrhosis) 01/2020 - 09/2004
6	Respiratory Hypersensitivity 09/2015 - 10/2008
5	Mitochondrial Diseases (Mitochondrial Disease) 09/2020 - 03/2015
4	COVID-19 01/2022 - 01/2021
4	Eosinophilia 01/2019 - 09/2002
4	Nausea 10/2018 - 03/2010
4	Headache (Headaches) 10/2018 - 05/2008
4	Dyspnea (Shortness of Breath) 01/2017 - 10/2005
4	Respiratory Tract Diseases (Respiratory Tract Disease) 09/2016 - 06/2002

Drug/Important Bio-Agent (IBA)

105	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2022 - 01/2002
39	SmokeIBA 01/2022 - 01/2003
39	SteroidsIBA 01/2022 - 01/2002
37	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2016 - 01/2002
34	CytokinesIBA 01/2022 - 01/2002
30	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2002
25	Theophylline (Theon)FDA LinkGeneric 01/2022 - 05/2002
24	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 11/2002
24	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2002
23	Bronchodilator Agents (Bronchodilators)IBA 12/2021 - 09/2002
22	Formoterol Fumarate (Oxis)FDA Link 12/2021 - 05/2002
20	GlucocorticoidsIBA 01/2021 - 04/2002
20	Histones (Histone)IBA 01/2017 - 01/2004
19	ChemokinesIBA 01/2022 - 01/2002
18	Interleukin-8 (Interleukin 8)IBA 01/2021 - 01/2003
17	AntioxidantsIBA 05/2022 - 01/2004
16	GoldIBA 03/2021 - 09/2002
16	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 01/2002
16	Transcription Factors (Transcription Factor)IBA 01/2016 - 04/2002
15	NF-kappa B (NF-kB)IBA 01/2017 - 02/2004
14	Pharmaceutical PreparationsIBA 11/2019 - 12/2003
13	8-epi-prostaglandin F2alphaIBA 05/2022 - 08/2002
13	InterleukinsIBA 01/2022 - 01/2002
13	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016 - 04/2002
12	EnzymesIBA 01/2022 - 08/2002
12	Histone Deacetylases (Histone Deacetylase)IBA 01/2017 - 01/2004
11	Interleukin-13IBA 01/2019 - 01/2002
11	Interleukin-4 (Interleukin 4)IBA 01/2018 - 01/2002
11	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2017 - 04/2002
10	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2002
9	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 01/2003
9	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 12/2002
9	Leukotriene B4IBA 01/2019 - 08/2002
8	Messenger RNA (mRNA)IBA 01/2022 - 02/2002
8	Interleukin-10 (Interleukin 10)IBA 12/2021 - 03/2002
8	Oxidants (Oxidizing Agents)IBA 01/2020 - 01/2004
8	Interleukin-5 (Interleukin 5)IBA 01/2019 - 08/2003
8	Fluticasone (Cutivate)FDA LinkGeneric 01/2018 - 09/2005
8	Phosphotransferases (Kinase)IBA 01/2016 - 12/2005
7	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2002
7	Adenosine (Adenocard)FDA LinkGeneric 01/2018 - 10/2005
7	Salmeterol Xinafoate (Serevent)FDA Link 01/2016 - 05/2002
7	Carbon MonoxideIBA 05/2014 - 01/2002
7	ProstaglandinsIBA 01/2012 - 04/2002
7	LeukotrienesIBA 08/2006 - 04/2002
6	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 05/2022 - 01/2002
6	Chemokine ReceptorsIBA 01/2022 - 01/2002
6	LigandsIBA 01/2022 - 05/2011
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2021 - 12/2008
6	Terbutaline (Brethaire)FDA LinkGeneric 12/2021 - 10/2017
6	Sirtuin 1IBA 08/2020 - 12/2008
6	Adenosine Triphosphate (ATP)IBA 01/2018 - 10/2005
6	OzoneIBA 06/2017 - 10/2011
6	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 02/2004
6	p38 Mitogen-Activated Protein KinasesIBA 01/2016 - 04/2002
6	AllergensIBA 12/2015 - 09/2002
6	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 10/2014 - 09/2004
6	Cholinergic Antagonists (Anticholinergics)IBA 01/2012 - 09/2002
5	Biological ProductsIBA 01/2022 - 11/2013
5	Formoterol Fumarate Drug Combination Budesonide FDA Link 12/2021 - 12/2011
5	Albuterol (Salbutamol)FDA LinkGeneric 03/2021 - 06/2003
5	Oxygen (Dioxygen)IBA 01/2021 - 01/2003
5	Interleukin-17 (Interleukin 17)IBA 01/2021 - 06/2011
5	MicroRNAs (MicroRNA)IBA 11/2019 - 03/2015
5	Immunoglobulin E (IgE)IBA 01/2019 - 06/2003
5	Adenosine Monophosphate (AMP)IBA 01/2017 - 10/2005
5	LipopolysaccharidesIBA 09/2016 - 08/2005
5	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2014 - 05/2002
5	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2014 - 03/2006
5	Nitric Oxide Synthase (NO Synthase)IBA 01/2010 - 03/2003
4	InterferonsIBA 01/2022 - 05/2002
4	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 12/2021 - 10/2005
4	AutoantibodiesIBA 01/2020 - 10/2011
4	Monoclonal AntibodiesIBA 01/2019 - 10/2006
4	Phosphodiesterase 4 InhibitorsIBA 01/2019 - 01/2006
4	Beclomethasone (Beclometasone)FDA Link 01/2018 - 12/2011
4	Capsaicin (Zostrix)FDA Link 01/2017 - 09/2003

Therapy/Procedure

122	Therapeutics 01/2022 - 01/2002
19	Nebulizers and Vaporizers (Inhaler) 01/2022 - 01/2003
10	Drug Therapy (Chemotherapy) 03/2021 - 05/2002